Press release
Tardive Dyskinesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & ResultsTardive Dyskinesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results
Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs which are prescribed to treat certain psychiatric or gastrointestinal conditions. Long-term use of these drugs may produce biochemical abnormalities in the area of the brain known as the striatum.Download the sample report @ https://www.pharmaproff.com/request-sample/1106
The reasons that some people who take these drugs may get TD, and some people do not, is unknown. Tardive dystonia is a more severe form of TD in which slower twisting movements of the neck and trunk muscles are prominent.
Get the detailed analysis @ https://www.pharmaproff.com/report/tardive-dyskinesia-therapeutics-pipeline-analysis
The typical symptoms of TD include facial grimacing, sticking out the tongue, and sucking or fish-like movements of the mouth. INGREZZA (valbenazine), developed by Neurocrine Biosciences Inc., is one of the key drugs developed for the treatment of TD.
Make enquiry before purchase @ https://www.pharmaproff.com/enquiry/1106
The drug candidates in TD pipeline include, but not limited to, SOM3355 and MT-5199. Some of the companies having drugs in the TD pipeline includes SOM INNOVATION BIOTECH, SL, and Mitsubishi Tanabe Pharma Corporation.
• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.
About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.
Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tardive Dyskinesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & ResultsTardive Dyskinesia Therapeutics- Pipeline Analysis 2018, Clinical Trials & Results here
News-ID: 1732793 • Views: …
More Releases for SOM
Future Electronics New Partner SolidRun Launches RZ/G2L System on Module (SoM)
Image: https://www.getnews.info/wp-content/uploads/2024/08/1722868032.jpeg
Future Electronics, a global leader in electronic component distribution, has partnered with SolidRun, a global leading developer of embedded systems and network solutions. SolidRun offers a full range of embedded edge IoT and industrial computing applications.
Montreal, Canada - August 5, 2024 - Future Electronics, a global leader in electronic component distribution, has partnered with SolidRun, a global leading developer of embedded systems and network solutions. SolidRun offers a full…
SE301 Carrier Board Supports Two Advanced SOM Devices
We are absolutely thrilled to announce the availability of our brand new #SE301 carrier board! 🎉 This state-of-the-art board supports two of the most advanced SOM devices - a high-performance #PolarFire #FPGA 🚀 (SOM1) and an innovative #PolarFireSoC 💡 (SOM1-SOC).
The SE301 is extremely versatile - it can be used as a standalone board or integrated into a host PC. It provides engineers and developers with a wide array of interfaces…
Know How System on Module (SOM) Market is rising globally by 2029
System on Module (SOM) Market Trends Overview 2023-2029:
The System on Module (SOM) Market report provides information about the Global industry, including valuable facts and figures. This research study explores the Global Market in detail such as industry chain structures, raw material suppliers, with manufacturing The System on Module (SOM) Sales market examines the primary segments of the scale of the market. This intelligent study provides historical data from 2018 alongside…
Mistral Announces AM65x Industrial SoM based on TI's AM6548 SoC
Enabling Real-time Processing, Connectivity and Control system for Industry 4.0 Applications
Bangalore, India, Tuesday, 25 February 2020: Mistral Solutions, a leading technology design and system engineering company, today announced the release of AM65x Industrial System on Module (SoM), enabled by the Texas Instruments AM6548 SoC. The AM65x Industrial SoM is an easy to use, compact, lightweight SoM providing very high processing power for Industrial Control and Communication applications.
Mistral's AM65x Industrial…
Global System on Module (SOM) Industry Market Analysis & Forecast
Global System on Module (SOM) Industry Market Analysis & Forecast 2018-2023, the revenue is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2018 and 2023. The production is estimated at XX million in 2017 and is forecasted to reach XX million by the end of 2023, growing at a CAGR of…
Global Nano Colloidal Copper Market 2019 - Purest Colloids, Starmed, Som Phytoph …
Nano Colloidal Copper is actually small flecks of copper mixed with purified water. The water acts as a vehicle for delivering the metal to the digestive system.
Get Free Sample Copy of Report Here: https://bit.ly/2DqwBu1
Scope of the Report:
Nano-copper colloids are widely used in the fields of catalysis, lubrication, magnetic fluids, etc.
The worldwide market for Nano Colloidal Copper is expected to grow at a CAGR of roughly xx% over the next…
